In suspected dermatomyositis, what are the expected serum lactate dehydrogenase (LDH) and creatine kinase (CK) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Expected Laboratory Results in Suspected Dermatomyositis

In suspected dermatomyositis, you should expect elevated creatine kinase (CK) and lactate dehydrogenase (LDH) levels, though the degree of elevation varies considerably and normal CK levels can occur in up to 49% of cases, particularly in patients with more severe disease or associated malignancy.

Expected Enzyme Elevations

Creatine Kinase (CK)

  • Elevated in approximately 51% of dermatomyositis patients at various disease stages 1
  • When elevated, CK levels can exceed 10 times the upper limit of normal, particularly in severe cases 2
  • Critical caveat: Normal CK levels in dermatomyositis carry a poor prognosis and are associated with either underlying malignancy or severe interstitial lung disease 3
  • One-year survival in dermatomyositis patients with normal CK was only 33% in one study 3

Lactate Dehydrogenase (LDH)

  • Elevated in approximately 60-87% of dermatomyositis patients 4, 1
  • LDH elevation is more frequent than CK elevation in dermatomyositis
  • LDH can be elevated even when CK is normal 5
  • Important clinical pearl: Rising LDH during corticosteroid treatment (when other enzymes are decreasing) may indicate underlying malignancy 6

Complete Expected Laboratory Pattern

Beyond CK and LDH, the diagnostic workup should reveal 5, 7:

Other muscle enzymes frequently elevated:

  • Aldolase: 65% of cases 1
  • AST (aspartate aminotransferase): 51% of cases 1
  • ALT (alanine aminotransferase): 43% of cases 1
  • Myoglobin: 48% of cases 1

Additional common abnormalities:

  • Elevated ESR (erythrocyte sedimentation rate): 33-56% of cases 4, 1
  • Low albumin: 22-26% of cases 4, 1
  • Low lymphocyte counts: 37% of cases 1
  • Low hematocrit: 29% of cases 1

Clinical Algorithm for Interpretation

  1. If CK and LDH are both elevated: Consistent with active dermatomyositis; proceed with EMG, MRI, and muscle biopsy as indicated 2, 8

  2. If LDH is elevated but CK is normal:

    • Still consistent with dermatomyositis (occurs in ~40% of cases)
    • High-risk scenario: Aggressively screen for malignancy and interstitial lung disease 3
    • Check aldolase, AST, ALT as alternative muscle enzyme markers 5
  3. If LDH rises during treatment while other enzymes fall: Strongly consider occult malignancy, particularly hepatic involvement 6

  4. Monitor CK-MB isoenzyme: Can be elevated (52% of cases) from skeletal muscle in dermatomyositis, not necessarily indicating cardiac involvement 1, 9

Key Pitfalls to Avoid

  • Do not rule out dermatomyositis based on normal CK alone—this actually suggests worse prognosis 3
  • Do not assume CK-MB elevation means myocardial infarction—skeletal muscle in dermatomyositis contains ~1.5% MB isoenzyme and releases it during inflammation 9
  • Do not ignore rising LDH during treatment—this pattern warrants malignancy screening even if other enzymes are improving 6
  • Elevated ESR is a specific risk factor for dermatomyositis-associated malignancy and should trigger comprehensive cancer screening 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.